79294724 - T ACELLT APEIRON CELL THERAPIES

Information

  • Trademark
  • 79294724
  • Serial Number
    79294724
  • Registration Number
    6799401
  • Filing Date
    August 03, 2020
    4 years ago
  • Registration Date
    July 26, 2022
    2 years ago
  • Transaction Date
    May 10, 2025
    a month ago
  • Status Date
    July 26, 2022
    2 years ago
  • Published for Opposition Date
    May 10, 2022
    3 years ago
  • Location Date
    July 26, 2022
    2 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    EISNACH, MICHAEL
  • Attorney Docket Number
    403146
    Attorney Name
    Julianne Abelman
    Law Office Assigned Location Code
    L40
  • Owners
Mark Drawing Code
3
Mark Identification
T ACELLT APEIRON CELL THERAPIES
Case File Statements
  • DM0000: The mark consists of the wording "ACELLT" with the "A" in blue font, the "T" in orange font, and the remaining letters in gray font. Below this is the wording "APEIRON CELL THERAPIES" in gray font. To the left of all the wording is stylized infinity symbol with the left portion of the symbol in blue, the middle of the symbol is an orange stylized "T" and the right portion of the symbol is gray. The white in the mark is background only and is not claimed as a feature of the mark.
  • GS0051: Pharmaceutical and veterinary preparations, namely, pharmaceutical preparations for treating and preventing cancer, pharmaceutical preparations for cellular therapy; diagnostic preparations for medical purposes; sanitary preparations for medical purposes
  • CC0000: The color(s) blue, gray, and orange is/are claimed as a feature of the mark.
  • GS0011: Chemical, biochemical and biotechnological preparations for industrial and scientific purposes
  • DS0000: "CELL THERAPIES"
  • GS0421: Scientific and technological services and research and design relating thereto, in particular analysis services in the field of research, development and diagnostics, namely, scientific research, medical research for medical applications, development of new products for others; industrial analysis and research services in the field of cancer treatment, cell processing, and cellular therapy
Case File Event Statements
  • 10/1/2020 - 4 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 10/9/2020 - 4 years ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 10/5/2020 - 4 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 11/24/2020 - 4 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 11/30/2020 - 4 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 12/9/2020 - 4 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 12/9/2020 - 4 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 12/27/2020 - 4 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 5/19/2021 - 4 years ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 5/19/2021 - 4 years ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 5/20/2021 - 4 years ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 12/1/2020 - 4 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 6/23/2021 - 4 years ago
    13 - FINAL REFUSAL WRITTEN Type: CNFR
  • 6/23/2021 - 4 years ago
    14 - FINAL REFUSAL E-MAILED Type: GNFR
  • 6/23/2021 - 4 years ago
    15 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 4/4/2022 - 3 years ago
    23 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 11/26/2021 - 3 years ago
    16 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 3/2/2022 - 3 years ago
    17 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR
  • 3/2/2022 - 3 years ago
    18 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 3/21/2022 - 3 years ago
    19 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX
  • 4/4/2022 - 3 years ago
    21 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 4/4/2022 - 3 years ago
    22 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 4/4/2022 - 3 years ago
    20 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 4/4/2022 - 3 years ago
    24 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 4/20/2022 - 3 years ago
    27 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 4/20/2022 - 3 years ago
    25 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 4/20/2022 - 3 years ago
    26 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 5/10/2022 - 3 years ago
    28 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 5/10/2022 - 3 years ago
    29 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 5/15/2022 - 3 years ago
    30 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 7/20/2022 - 2 years ago
    33 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR
  • 7/20/2022 - 2 years ago
    34 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 7/20/2022 - 2 years ago
    31 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 7/20/2022 - 2 years ago
    32 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 7/26/2022 - 2 years ago
    35 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 10/28/2022 - 2 years ago
    39 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 7/26/2022 - 2 years ago
    36 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 10/26/2022 - 2 years ago
    37 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 10/27/2022 - 2 years ago
    38 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 11/20/2022 - 2 years ago
    40 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 11/4/2023 - a year ago
    41 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 1/16/2025 - 5 months ago
    42 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH
  • 5/9/2025 - a month ago
    43 - RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED Type: RHRD